@greenstonebio.bsky.social
As we count down to Rare Disease Day on February 28, we at @greenstonebio.bsky.social will be spotlighting rare diseases represented in our iPSC biobank. This week, we are highlighting neuromuscular rare diseases.
Read more here: www.linkedin.com/posts/greens...
Read more here: www.linkedin.com/posts/greens...
February 10, 2026 at 7:20 PM
As we count down to Rare Disease Day on February 28, we at @greenstonebio.bsky.social will be spotlighting rare diseases represented in our iPSC biobank. This week, we are highlighting neuromuscular rare diseases.
Read more here: www.linkedin.com/posts/greens...
Read more here: www.linkedin.com/posts/greens...
Earlier this week, our Co-Founder, Dr. Joseph C. Wu, was featured as a guest on the @stemcellpodcast.com, discussing his work with iPSCs, vaccine-induced myocarditis, and New Approach Methodologies (NAMs).
You can listen to the full episode here:
stemcellpodcast.com/ep-313-cardi...
You can listen to the full episode here:
stemcellpodcast.com/ep-313-cardi...
Ep. 313: "Cardiovascular Disease Mechanisms" Featuring Dr. Joseph Wu - The Stem Cell Podcast
Dr. Joseph Wu is a Professor of Medicine and Radiology and the Director of the Stanford Cardiovascular Institute. He talks about the importance of pharmacology knowledge in drug discovery. He also dis...
stemcellpodcast.com
February 6, 2026 at 7:10 PM
Earlier this week, our Co-Founder, Dr. Joseph C. Wu, was featured as a guest on the @stemcellpodcast.com, discussing his work with iPSCs, vaccine-induced myocarditis, and New Approach Methodologies (NAMs).
You can listen to the full episode here:
stemcellpodcast.com/ep-313-cardi...
You can listen to the full episode here:
stemcellpodcast.com/ep-313-cardi...
300+ million people worldwide are living with a rare disease. In the US alone, 1 in 10 Americans is affected. At @greenstonebio.bsky.social, supporting research into rare diseases with our iPSC biobank is a core focus of our mission.
Learn more here: www.linkedin.com/posts/greens...
Learn more here: www.linkedin.com/posts/greens...
February 2, 2026 at 9:39 PM
300+ million people worldwide are living with a rare disease. In the US alone, 1 in 10 Americans is affected. At @greenstonebio.bsky.social, supporting research into rare diseases with our iPSC biobank is a core focus of our mission.
Learn more here: www.linkedin.com/posts/greens...
Learn more here: www.linkedin.com/posts/greens...
@greenstonebio.bsky.social is offering patient-derived iPSC-derived lines carrying Facioscapulohumeral muscular dystrophy (FSHD). FSHD is one of the most common inherited muscular dystrophies, affecting nearly 1 in 8,000 individuals worldwide.
Read more Here: www.linkedin.com/posts/greens...
Read more Here: www.linkedin.com/posts/greens...
Generation of two induced pluripotent stem cell lines from patients with Facioscapulohumeral muscular dystrophy - PubMed | Greenstone Biosciences
Greenstone Biosciences is offering specialized patient-derived induced pluripotent stem cell (iPSC)-derived lines carrying Facioscapulohumeral muscular dystrophy (FSHD)–associated mutations to help re...
www.linkedin.com
January 28, 2026 at 7:23 PM
@greenstonebio.bsky.social is offering patient-derived iPSC-derived lines carrying Facioscapulohumeral muscular dystrophy (FSHD). FSHD is one of the most common inherited muscular dystrophies, affecting nearly 1 in 8,000 individuals worldwide.
Read more Here: www.linkedin.com/posts/greens...
Read more Here: www.linkedin.com/posts/greens...
Earlier this week @greenstonebio.bsky.social Co-Founder Joseph Wu spoke at the WuXi Global Forum 2026 in San Francisco, joining leaders from UCSF, Arena Bioworks, and the Parker Institute to discuss what we should strive toward for patients.
Read more here: www.linkedin.com/posts/greens...
Read more here: www.linkedin.com/posts/greens...
January 19, 2026 at 8:29 PM
Earlier this week @greenstonebio.bsky.social Co-Founder Joseph Wu spoke at the WuXi Global Forum 2026 in San Francisco, joining leaders from UCSF, Arena Bioworks, and the Parker Institute to discuss what we should strive toward for patients.
Read more here: www.linkedin.com/posts/greens...
Read more here: www.linkedin.com/posts/greens...
Last Sunday, Greenstone Founder Dr. Joseph C. Wu moderated a debate at the UCSF-CERSI conference on the future of animal testing and the rapid advances with NAMs.
These are the discussions the field needs, and we’re proud to see our founder driving them forward!
These are the discussions the field needs, and we’re proud to see our founder driving them forward!
January 13, 2026 at 7:07 PM
Last Sunday, Greenstone Founder Dr. Joseph C. Wu moderated a debate at the UCSF-CERSI conference on the future of animal testing and the rapid advances with NAMs.
These are the discussions the field needs, and we’re proud to see our founder driving them forward!
These are the discussions the field needs, and we’re proud to see our founder driving them forward!
In case you missed it live, the newest Greenstone Biosciences Webinar featuring Dr. Mark Mercola, Professor of Medicine and Professor in the @stanfordcvi.bsky.social is now available to watch for free online!
Watch it here: www.youtube.com/watch?v=k3yh...
Watch it here: www.youtube.com/watch?v=k3yh...
Greenstone Biosciences Webinar Series: Dr. Mark Mercola
YouTube video by Greenstone Biosciences
www.youtube.com
January 8, 2026 at 7:06 PM
In case you missed it live, the newest Greenstone Biosciences Webinar featuring Dr. Mark Mercola, Professor of Medicine and Professor in the @stanfordcvi.bsky.social is now available to watch for free online!
Watch it here: www.youtube.com/watch?v=k3yh...
Watch it here: www.youtube.com/watch?v=k3yh...
Earlier this week, the U.S. Senate passed the FDA Modernization Act 3.0, requiring the @fda.gov to update its regulations to replace references to “animal” testing with “nonclinical” methods.
Learn more about how @greenstonebio.bsky.social is supporting this shift: www.linkedin.com/posts/greens...
Learn more about how @greenstonebio.bsky.social is supporting this shift: www.linkedin.com/posts/greens...
Senate clears FDA Modernization Act 3.0, aiming to align FDA regulations with nonclinical-testing reforms | Greenstone Biosciences
Earlier this week, the U.S. Senate unanimously passed the FDA Modernization Act 3.0. This bill will require the FDA to update its regulations to replace references to “animal” testing with “nonclinica...
www.linkedin.com
December 19, 2025 at 7:05 PM
Earlier this week, the U.S. Senate passed the FDA Modernization Act 3.0, requiring the @fda.gov to update its regulations to replace references to “animal” testing with “nonclinical” methods.
Learn more about how @greenstonebio.bsky.social is supporting this shift: www.linkedin.com/posts/greens...
Learn more about how @greenstonebio.bsky.social is supporting this shift: www.linkedin.com/posts/greens...
We are 1 week away from the next entry in the
@greenstonebio.bsky.social webinar series, featuring Dr. Mark Mercola, Professor at @stanfordmedicine.bsky.social and the Stanford Cardiovascular Institute
Register here:https://us06web.zoom.us/webinar/register/WN_eZ2jB3SkQzOvrCW4b2CbzQ#/registration
@greenstonebio.bsky.social webinar series, featuring Dr. Mark Mercola, Professor at @stanfordmedicine.bsky.social and the Stanford Cardiovascular Institute
Register here:https://us06web.zoom.us/webinar/register/WN_eZ2jB3SkQzOvrCW4b2CbzQ#/registration
December 9, 2025 at 9:20 PM
We are 1 week away from the next entry in the
@greenstonebio.bsky.social webinar series, featuring Dr. Mark Mercola, Professor at @stanfordmedicine.bsky.social and the Stanford Cardiovascular Institute
Register here:https://us06web.zoom.us/webinar/register/WN_eZ2jB3SkQzOvrCW4b2CbzQ#/registration
@greenstonebio.bsky.social webinar series, featuring Dr. Mark Mercola, Professor at @stanfordmedicine.bsky.social and the Stanford Cardiovascular Institute
Register here:https://us06web.zoom.us/webinar/register/WN_eZ2jB3SkQzOvrCW4b2CbzQ#/registration
We are 2 weeks away from the next entry in the
@greenstonebio.bsky.social webinar series, featuring Dr. Mark Mercola, Professor at @stanfordmedicine.bsky.social and the Stanford Cardiovascular Institute
Register here:https://us06web.zoom.us/webinar/register/WN_eZ2jB3SkQzOvrCW4b2CbzQ#/registration
@greenstonebio.bsky.social webinar series, featuring Dr. Mark Mercola, Professor at @stanfordmedicine.bsky.social and the Stanford Cardiovascular Institute
Register here:https://us06web.zoom.us/webinar/register/WN_eZ2jB3SkQzOvrCW4b2CbzQ#/registration
December 2, 2025 at 7:15 PM
We are 2 weeks away from the next entry in the
@greenstonebio.bsky.social webinar series, featuring Dr. Mark Mercola, Professor at @stanfordmedicine.bsky.social and the Stanford Cardiovascular Institute
Register here:https://us06web.zoom.us/webinar/register/WN_eZ2jB3SkQzOvrCW4b2CbzQ#/registration
@greenstonebio.bsky.social webinar series, featuring Dr. Mark Mercola, Professor at @stanfordmedicine.bsky.social and the Stanford Cardiovascular Institute
Register here:https://us06web.zoom.us/webinar/register/WN_eZ2jB3SkQzOvrCW4b2CbzQ#/registration
Recently, the @fda.gov unveiled the Plausible Mechanism Pathway, a new approval route that lets some therapies gain authorization without traditional randomized controlled trials.
Learn more about how @greenstonebio.bsky.social is supporting this shift here: www.linkedin.com/feed/update/...
Learn more about how @greenstonebio.bsky.social is supporting this shift here: www.linkedin.com/feed/update/...
Services | Greenstone Biosciences
Recently, the FDA unveiled a major regulatory innovation: the Plausible Mechanism Pathway, a new approval route that allows certain therapies—especially those targeting rare genetic diseases—to obtain...
www.linkedin.com
December 1, 2025 at 7:09 PM
Recently, the @fda.gov unveiled the Plausible Mechanism Pathway, a new approval route that lets some therapies gain authorization without traditional randomized controlled trials.
Learn more about how @greenstonebio.bsky.social is supporting this shift here: www.linkedin.com/feed/update/...
Learn more about how @greenstonebio.bsky.social is supporting this shift here: www.linkedin.com/feed/update/...
We are excited to announce the newest entry in the
@greenstonebio.bsky.social webinar series, featuring Dr. Mark Mercola, Professor of Medicine at @stanfordmedicine.bsky.social and Professor in the Stanford Cardiovascular Institute
Register here: us06web.zoom.us/webinar/regi...
@greenstonebio.bsky.social webinar series, featuring Dr. Mark Mercola, Professor of Medicine at @stanfordmedicine.bsky.social and Professor in the Stanford Cardiovascular Institute
Register here: us06web.zoom.us/webinar/regi...
November 25, 2025 at 7:30 PM
We are excited to announce the newest entry in the
@greenstonebio.bsky.social webinar series, featuring Dr. Mark Mercola, Professor of Medicine at @stanfordmedicine.bsky.social and Professor in the Stanford Cardiovascular Institute
Register here: us06web.zoom.us/webinar/regi...
@greenstonebio.bsky.social webinar series, featuring Dr. Mark Mercola, Professor of Medicine at @stanfordmedicine.bsky.social and Professor in the Stanford Cardiovascular Institute
Register here: us06web.zoom.us/webinar/regi...
Our latest post in the @greenstonebio.bsky.social gut organoid series highlights how we support researchers in evaluating gastrointestinal (GI) toxicity using human-relevant in-vitro systems.
Read more here: www.linkedin.com/feed/update/...
Read more here: www.linkedin.com/feed/update/...
#nams #drugdiscovery #ipsc #organoids #gutorganoids #biotech #greenstonebiosciences | Greenstone Biosciences
Our latest post in Greenstone Biosciences’ gut organoid series highlights how we support researchers in evaluating gastrointestinal (GI) toxicity using human-relevant in-vitro systems.
We use a range...
www.linkedin.com
November 20, 2025 at 7:09 PM
Our latest post in the @greenstonebio.bsky.social gut organoid series highlights how we support researchers in evaluating gastrointestinal (GI) toxicity using human-relevant in-vitro systems.
Read more here: www.linkedin.com/feed/update/...
Read more here: www.linkedin.com/feed/update/...
This week, the UK announced a plan to accelerate the transition toward NAMs. At @GreenstoneBio we already see human iPSC-derived systems are rapidly becoming essential tools for drug discovery and safety testing.
Read more here: www.linkedin.com/feed/update/...
Read more here: www.linkedin.com/feed/update/...
Services | Greenstone Biosciences
This week, the UK government announced an ambitious plan backed by £75 million to accelerate the transition toward human-relevant alternative methods, including organ-on-chip systems, advanced AI mode...
www.linkedin.com
November 13, 2025 at 7:11 PM
This week, the UK announced a plan to accelerate the transition toward NAMs. At @GreenstoneBio we already see human iPSC-derived systems are rapidly becoming essential tools for drug discovery and safety testing.
Read more here: www.linkedin.com/feed/update/...
Read more here: www.linkedin.com/feed/update/...
We’re thrilled to share that @greenstonebio.bsky.social is a proud sponsor of the 2026 Stanford Drug Discovery Symposium. This will be our third year sponsoring this event!
You can join us and register for SDDS 2026 here: med.stanford.edu/cvi/events/s...
You can join us and register for SDDS 2026 here: med.stanford.edu/cvi/events/s...
November 11, 2025 at 7:02 PM
We’re thrilled to share that @greenstonebio.bsky.social is a proud sponsor of the 2026 Stanford Drug Discovery Symposium. This will be our third year sponsoring this event!
You can join us and register for SDDS 2026 here: med.stanford.edu/cvi/events/s...
You can join us and register for SDDS 2026 here: med.stanford.edu/cvi/events/s...
In case you missed it live, the newest @greenstonebio.bsky.social Webinar featuring Dr. William Pu, Professor of Pediatrics at @harvardmed.bsky.social is now available to watch for free online!
Catch the full recording here: lnkd.in/gtTFeBjZ
Catch the full recording here: lnkd.in/gtTFeBjZ
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
November 6, 2025 at 7:04 PM
In case you missed it live, the newest @greenstonebio.bsky.social Webinar featuring Dr. William Pu, Professor of Pediatrics at @harvardmed.bsky.social is now available to watch for free online!
Catch the full recording here: lnkd.in/gtTFeBjZ
Catch the full recording here: lnkd.in/gtTFeBjZ
We’re excited to announce that @greenstonebio.bsky.social is partnering with NVIDIA to accelerate drug discovery through the application of advanced AI foundational models, combining NVIDIA's computational power with our drug discovery methods.
Read more: www.biopharmadive.com/press-releas...
Read more: www.biopharmadive.com/press-releas...
Greenstone Biosciences Advances AI-Driven Human Models for Drug Safety and Efficacy with NVIDIA | BioPharma Dive
BioPharma
www.biopharmadive.com
October 29, 2025 at 5:59 PM
We’re excited to announce that @greenstonebio.bsky.social is partnering with NVIDIA to accelerate drug discovery through the application of advanced AI foundational models, combining NVIDIA's computational power with our drug discovery methods.
Read more: www.biopharmadive.com/press-releas...
Read more: www.biopharmadive.com/press-releas...
Today is just one day away from the next installment of our Greenstone Biosciences webinar series, featuring Dr. William Pu. Professor of Pediatrics at @harvardmed.bsky.social on Tuesday, October 28th.
Learn more: linkedin.com/posts/greens...
Secure your spot: us06web.zoom.us/webinar/regi...
Learn more: linkedin.com/posts/greens...
Secure your spot: us06web.zoom.us/webinar/regi...
October 27, 2025 at 5:12 PM
Today is just one day away from the next installment of our Greenstone Biosciences webinar series, featuring Dr. William Pu. Professor of Pediatrics at @harvardmed.bsky.social on Tuesday, October 28th.
Learn more: linkedin.com/posts/greens...
Secure your spot: us06web.zoom.us/webinar/regi...
Learn more: linkedin.com/posts/greens...
Secure your spot: us06web.zoom.us/webinar/regi...
Greenstone Biosciences is partnering with Illumina to advance precision drug discovery. This collaboration combines Greenstone’s extensive iPSC biobank with Illumina’s cutting-edge single-cell and spatial genomics technologies.
Read More: www.biopharmadive.com/press-releas...
Read More: www.biopharmadive.com/press-releas...
Greenstone Biosciences and Illumina announce collaboration to advance precision drug discovery | BioPharma Dive
BioPharma
www.biopharmadive.com
October 24, 2025 at 5:03 PM
Greenstone Biosciences is partnering with Illumina to advance precision drug discovery. This collaboration combines Greenstone’s extensive iPSC biobank with Illumina’s cutting-edge single-cell and spatial genomics technologies.
Read More: www.biopharmadive.com/press-releas...
Read More: www.biopharmadive.com/press-releas...
Greenstone Bioscience's very own Director of the hiPSC Biobank, Dr Todd Herron, PhD, has co-authored a commentary in @nature.com: “Alternatives to animal testing are the future — it’s time that journals, funders and scientists embrace them.”
Read it here: www.nature.com/articles/d41...
Read it here: www.nature.com/articles/d41...
Alternatives to animal testing are the future — it’s time that journals, funders and scientists embrace them
Biomedical research techniques that don’t involve the use of animals are gaining momentum, but those using innovative approaches still face resistance from some quarters.
www.nature.com
October 23, 2025 at 6:08 PM
Greenstone Bioscience's very own Director of the hiPSC Biobank, Dr Todd Herron, PhD, has co-authored a commentary in @nature.com: “Alternatives to animal testing are the future — it’s time that journals, funders and scientists embrace them.”
Read it here: www.nature.com/articles/d41...
Read it here: www.nature.com/articles/d41...
Tomorrow our biobank director Dr. Todd Herron will be speaking in the Cellular Insights Series: Innovations and Ethics in Stem Cell Research, presented by Wiley and @ascbiology.bsky.social
Date: October 23, 2025 Time: 12:00 – 1:00 PM ET
Sign up here: events.bizzabo.com/765090?utm_s...
Date: October 23, 2025 Time: 12:00 – 1:00 PM ET
Sign up here: events.bizzabo.com/765090?utm_s...
October 22, 2025 at 8:47 PM
Tomorrow our biobank director Dr. Todd Herron will be speaking in the Cellular Insights Series: Innovations and Ethics in Stem Cell Research, presented by Wiley and @ascbiology.bsky.social
Date: October 23, 2025 Time: 12:00 – 1:00 PM ET
Sign up here: events.bizzabo.com/765090?utm_s...
Date: October 23, 2025 Time: 12:00 – 1:00 PM ET
Sign up here: events.bizzabo.com/765090?utm_s...
We are now one week out from the next installment of our Greenstone Biosciences webinar series, featuring Dr. William Pu. Professor of Pediatrics at Harvard Medical School on Tuesday, October 28th. Learn more: linkedin.com/posts/greens... Secure your spot: us06web.zoom.us/webinar/regi...
October 21, 2025 at 6:02 PM
We are now one week out from the next installment of our Greenstone Biosciences webinar series, featuring Dr. William Pu. Professor of Pediatrics at Harvard Medical School on Tuesday, October 28th. Learn more: linkedin.com/posts/greens... Secure your spot: us06web.zoom.us/webinar/regi...
We’re excited to share that Dr. Todd Herron, Director of our hiPSC Biobank, will be a featured speaker in the upcoming Cellular Insights Series: Innovations and Ethics in Stem Cell Research.
Date: October 23, 2025
Time: 12:00 – 1:00 PM ET
Sign up here: www.ascb.org/ascb-meeting...
Date: October 23, 2025
Time: 12:00 – 1:00 PM ET
Sign up here: www.ascb.org/ascb-meeting...
Cellular Insights Series: Innovations and Ethics in Stem Cell Research - ASCB
Featured Session: Bridging Innovations and Ethics in Stem Cell Research The stem cell field stands at a transformative crossroads where breakthrough technologies are rapidly advancing from laboratory ...
www.ascb.org
October 17, 2025 at 6:02 PM
We’re excited to share that Dr. Todd Herron, Director of our hiPSC Biobank, will be a featured speaker in the upcoming Cellular Insights Series: Innovations and Ethics in Stem Cell Research.
Date: October 23, 2025
Time: 12:00 – 1:00 PM ET
Sign up here: www.ascb.org/ascb-meeting...
Date: October 23, 2025
Time: 12:00 – 1:00 PM ET
Sign up here: www.ascb.org/ascb-meeting...
We’re excited to announce that Greenstone Biosciences now offers comprehensive gut permeability assays to support drug discovery.
These assays help evaluate:
- Barrier dysfunction in disease models
- Drug-induced effects on tight junctions
- Restoration of barrier integrity
These assays help evaluate:
- Barrier dysfunction in disease models
- Drug-induced effects on tight junctions
- Restoration of barrier integrity
October 16, 2025 at 7:10 PM
We’re excited to announce that Greenstone Biosciences now offers comprehensive gut permeability assays to support drug discovery.
These assays help evaluate:
- Barrier dysfunction in disease models
- Drug-induced effects on tight junctions
- Restoration of barrier integrity
These assays help evaluate:
- Barrier dysfunction in disease models
- Drug-induced effects on tight junctions
- Restoration of barrier integrity
We’re proud to share a new publication resulting from a collaboration between Greenstone Biosciences and the Stanford Cardiovascular Institute, advancing the study of inherited cardiovascular disease.
Read the full paper here: lnkd.in/g8djR-9H
Read the full paper here: lnkd.in/g8djR-9H
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
October 14, 2025 at 6:08 PM
We’re proud to share a new publication resulting from a collaboration between Greenstone Biosciences and the Stanford Cardiovascular Institute, advancing the study of inherited cardiovascular disease.
Read the full paper here: lnkd.in/g8djR-9H
Read the full paper here: lnkd.in/g8djR-9H